标题
The safety and efficacy of metformin in fragile X syndrome: An open-label study
作者
关键词
Fragile X syndrome, Metformin, Behavior, Cognition, Cortical excitability, Inhibitory mechanisms
出版物
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Volume 110, Issue -, Pages 110307
出版商
Elsevier BV
发表日期
2021-03-21
DOI
10.1016/j.pnpbp.2021.110307
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Validation of the NIH Toolbox Cognitive Battery in intellectual disability
- (2020) Rebecca H. Shields et al. NEUROLOGY
- Metformin treatment in young children with fragile X syndrome
- (2019) Hazel Maridith B. Biag et al. Molecular Genetics & Genomic Medicine
- Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome
- (2019) Florence Morin-Parent et al. Translational Psychiatry
- The influence of metformin on IGF-1 levels in humans: A systematic review and meta-analysis
- (2019) Xiaodong Yang et al. PHARMACOLOGICAL RESEARCH
- Facilitation of hippocampal long-term potentiation and reactivation of latent HIV-1 via AMPK activation: Common mechanism of action linking learning, memory, and the potential eradication of HIV-1
- (2018) Jahahreeh Finley MEDICAL HYPOTHESES
- Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders
- (2018) Ilse Gantois et al. Annual Review of Medicine
- Metformin produces anxiolytic-like effects in rats by facilitating GABAA receptor trafficking to membrane
- (2018) Jun Fan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome
- (2017) Ji-Yong Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
- (2017) Dejan B. Budimirovic et al. Journal of Neurodevelopmental Disorders
- Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
- (2017) Elizabeth M. Berry-Kravis et al. NATURE REVIEWS DRUG DISCOVERY
- Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet’s signaling cascades as new outcome measures in clinical trials
- (2016) David Pellerin et al. BIOMARKERS
- Pharmacotherapy for Fragile X Syndrome: Progress to Date
- (2016) Matthew H. Davenport et al. DRUGS
- Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome
- (2016) Lindsay M. Oberman et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model
- (2016) R E Monyak et al. MOLECULAR PSYCHIATRY
- The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity
- (2016) Adam H. Dyer et al. NEUROSCIENCE
- Insulin-Like Growth Factor 1 and Related Compounds in the Treatment of Childhood-Onset Neurodevelopmental Disorders
- (2016) Cyrus Vahdatpour et al. Frontiers in Neuroscience
- TMS and drugs revisited 2014
- (2015) Ulf Ziemann et al. CLINICAL NEUROPHYSIOLOGY
- Single-Molecule Imaging of PSD-95 mRNA Translation in Dendrites and Its Dysregulation in a Mouse Model of Fragile X Syndrome
- (2015) M. F. Ifrim et al. JOURNAL OF NEUROSCIENCE
- GABABreceptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome
- (2015) Sarah Wahlstrom-Helgren et al. JOURNAL OF PHYSIOLOGY-LONDON
- Gene expression analysis in Fmr1KO mice identifies an immunological signature in brain tissue and mGluR5-related signaling in primary neuronal cultures
- (2015) Daria Prilutsky et al. Molecular Autism
- A commonSCN1Asplice-site polymorphism modifies the effect of carbamazepine on cortical excitability-A pharmacogenetic transcranial magnetic stimulation study
- (2014) Katja Menzler et al. EPILEPSIA
- Task-dependent changes in late inhibitory and disinhibitory actions within the primary motor cortex in humans
- (2014) Alexandre Caux-Dedeystère et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome
- (2014) D. Colak et al. SCIENCE
- The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer
- (2013) Vladimir N. Anisimov et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Minireview: Nuclear Insulin and Insulin-like Growth Factor-1 Receptors: A Novel Paradigm in Signal Transduction
- (2013) Rive Sarfstein et al. ENDOCRINOLOGY
- Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome
- (2013) Randi Hagerman et al. LANCET NEUROLOGY
- Fragile X Syndrome
- (2012) Yingratana McLennan et al. CURRENT GENOMICS
- Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
- (2012) Andrew Knox et al. Journal of Neurodevelopmental Disorders
- Inhibitory and Disinhibitory Effects on I-Wave Facilitation in Motor Cortex
- (2010) R.F.H. Cash et al. JOURNAL OF NEUROPHYSIOLOGY
- Fragile X syndrome
- (2008) Kathryn B Garber et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome
- (2008) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now